Table 1.
The examined data sets and their data types.
| Set | Compounds | Congeneric? | Data type (N) | Reference |
|---|---|---|---|---|
| Avdeef | FDA drugs | No | PAMPA (11) | 66 |
| Caco-2 (11) | ||||
| Balamine | FDA drugs | No | PAMPA (22) | 67 |
| Caco-2 (21) | ||||
| %Abs (22) | ||||
| Bermejo | Fluoroquinolones | Yes | PAMPA (16) | 68 |
| Caco2 (14) | ||||
| Perfusion assay (16) | ||||
| Di | FDA drugs | No | PAMPA (27) | 69 |
| Fujikawa | FDA drugs & small chemicals | No | PAMPA (70) | 70 |
| Caco-2 (29) | ||||
| Goodwin | Peptidomimetics | Yes | Caco-2 (12) | 71 |
| Irvine | FDA drugs | No | Caco-2 (50) | 72 |
| MDCK (51) | ||||
| %Abs (53) | ||||
| Li | Peptidomimetics | Yes | PAMPA (25) | 73 |
| Caco-2 (25) | ||||
| Whitlock | 1-(2-Phenoxyphenyl) methanamines | Yes | PAMPA (8) | 74 |